821
Views
20
CrossRef citations to date
0
Altmetric
Review Article

Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review

, , , &
Pages 102-114 | Received 28 Mar 2015, Accepted 01 Nov 2015, Published online: 03 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Paweł Małecki, Joanna Tracz, Magdalena Łuczak, Magdalena Figlerowicz, Katarzyna Mazur-Melewska, Wojciech Służewski & Anna Mania. (2020) Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study. Expert Review of Proteomics 17:7-8, pages 623-632.
Read now

Articles from other publishers (19)

Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Elena Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, Vasile Andrei Olteanu & Gabriela Ștefănescu. (2023) Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease. Metabolites 13:11, pages 1115.
Crossref
Agnieszka Karkucinska‐Wieckowska, Ines C. M. Simoes, Piotr Kalinowski, Magdalena Lebiedzinska‐Arciszewska, Krzysztof Zieniewicz, Piotr Milkiewicz, Magdalena Górska‐Ponikowska, Paolo Pinton, Afshan N. Malik, Marcin Krawczyk, Paulo J. Oliveira & Mariusz R. Wieckowski. (2021) Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship. European Journal of Clinical Investigation 52:3.
Crossref
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur & Angeliki M. Angelidi. (2022) Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics 12:2, pages 407.
Crossref
Lili Niu, Karolina Sulek, Catherine G. Vasilopoulou, Alberto Santos, Nicolai J. Wewer Albrechtsen, Simon Rasmussen, Florian Meier & Matthias Mann. (2021) Defining NASH from a Multi-Omics Systems Biology Perspective. Journal of Clinical Medicine 10:20, pages 4673.
Crossref
James A. Richards, Lucy V. Randle, Andrew J. Butler MChir, Jack L. Martin, Arturs Fedotovs, Susan E. Davies, Christopher J.E. Watson & Paul A. Robertson. (2021) Pilot study of a noninvasive real‐time optical backscatter probe in liver transplantation. Transplant International 34:4, pages 709-720.
Crossref
Shannon Kogachi & Mazen Noureddin. (2021) Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clinical Therapeutics 43:3, pages 455-472.
Crossref
Anca Bălănescu, Ioana Florentina Codreanu, Valentina Daniela Comanici, Iustina Violeta Stan, Eugenia Bălănescu & Paul Bălănescu. (2020) Endocan and Lumican in Relation to Cardiometabolic Risk in a Pediatric Overweight and Obese Cohort: A Cross-Sectional Study. BioMed Research International 2020, pages 1-11.
Crossref
Shivaram P. Singh & Rakesh K. Barik. (2020) NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?. Journal of Clinical and Experimental Hepatology 10:1, pages 88-98.
Crossref
Anca Bălănescu, Iustina Stan, Ioana Codreanu, Valentina Comănici, Eugenia Bălănescu & Paul Bălănescu. (2019) Circulating Hsp90 Isoform Levels in Overweight and Obese Children and the Relation to Nonalcoholic Fatty Liver Disease: Results from a Cross-Sectional Study. Disease Markers 2019, pages 1-6.
Crossref
Prahlad K. Rao, Kate Merath, Eugene Drigalenko, Avinash Y. L. Jadhav, Richard A. Komorowski, Matthew I. Goldblatt, Anand Rohatgi, Mark A. Sarzynski, Samer Gawrieh & Michael Olivier. (2018) Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease. Clinical Proteomics 15:1.
Crossref
Sina Mohagheghi, Zohreh Khajehahmadi & Heidar Tavilani. (2018) Signaling in Simple Steatosis and Non-alcoholic Steatohepatitis Cirrhosis: TGF-β1, YAP/TAZ, and Hedgehog Pathway Activity. Avicenna Journal of Medical Biochemistry 6:2, pages 26-30.
Crossref
Fabrizio Ceciliani, Cristina Lecchi, Christiane Urh & Helga Sauerwein. (2018) Proteomics and metabolomics characterizing the pathophysiology of adaptive reactions to the metabolic challenges during the transition from late pregnancy to early lactation in dairy cows. Journal of Proteomics 178, pages 92-106.
Crossref
Eduardo Vilar-Gomez & Naga Chalasani. (2018) Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. Journal of Hepatology 68:2, pages 305-315.
Crossref
Simone G.J. van Breda, Sandra M.H. Claessen, Marcel van Herwijnen, Daniël H.J. Theunissen, Danyel G.J. Jennen, Theo M.C.M. de Kok & Jos C.S. Kleinjans. (2018) Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology 393, pages 160-170.
Crossref
Manuel Suárez, Noemí Boqué, Josep del Bas, Jordi Mayneris-Perxachs, Lluís Arola & Antoni Caimari. (2017) Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 9:10, pages 1052.
Crossref
Michal Marczyk, Joanna Polanska & Andrzej Polanski. (2017) Improving peak detection by Gaussian mixture modeling of mass spectral signal. Improving peak detection by Gaussian mixture modeling of mass spectral signal.
G. Craig Wood, Xin Chu, George Argyropoulos, Peter Benotti, David Rolston, Tooraj Mirshahi, Anthony Petrick, John Gabrielson, David J. Carey, Johanna K. DiStefano, Christopher D. Still & Glenn S. Gerhard. (2017) A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains. Scientific Reports 7:1.
Crossref
Xuelin Zhang, Yang Wang & Pingsheng Liu. (2016) Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease. Protein & Cell 8:1, pages 4-13.
Crossref
Maria Grazia Clemente, Claudia Mandato, Marco Poeta & Pietro Vajro. (2016) Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. World Journal of Gastroenterology 22:36, pages 8078.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.